{"entity":{"type":"insider","cik":"0001767650","url":"/insider/0001767650","json_url":"/insider/0001767650.json","name":"Stephenson Pamela","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":24,"first":"2020-03-25","last":"2026-02-17","span_basis":"filed_date"},"name_variants":[{"name":"Stephenson Pamela","source":"filing","n_filings":24,"first_seen":"2020-03-25","last_seen":"2026-02-17"}],"transactions":[{"id":5847059,"accession":"0001193125-26-055646","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-055646","line_url":"/filing/0001193125-26-055646#line-1","is_derivative":false,"issuer_cik":"0001767650","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001767650","owner_cik":"0001767650","owner_name":"Stephenson Pamela","owner_url":"/insider/0001767650","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5531.0,"shares_display":"5,531","price_per_share":62.86,"price_display":"62.86","price_state":"stated","total_value":347678.66,"total_display":"347,678.66","shares_owned_after":80998.0,"shares_owned_after_display":"80,998","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-17","filed_date":"2026-02-17","scope":"insider"},{"id":4582525,"accession":"0000950170-25-024477","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-024477","line_url":"/filing/0000950170-25-024477#line-1","is_derivative":false,"issuer_cik":"0001767650","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001767650","owner_cik":"0001767650","owner_name":"Stephenson Pamela","owner_url":"/insider/0001767650","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3137.0,"shares_display":"3,137","price_per_share":54.58,"price_display":"54.58","price_state":"stated","total_value":171217.46,"total_display":"171,217.46","shares_owned_after":69529.0,"shares_owned_after_display":"69,529","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-18","filed_date":"2025-02-20","scope":"insider"},{"id":8252361,"accession":"0001062993-23-013668","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-013668","line_url":"/filing/0001062993-23-013668#line-2","is_derivative":false,"issuer_cik":"0001621443","issuer_name":"Zynerba Pharmaceuticals, Inc.","issuer_ticker":"ZYNE","issuer_name_source":null,"issuer_url":"/issuer/0001621443","owner_cik":"0001767650","owner_name":"Stephenson Pamela","owner_url":"/insider/0001767650","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":115.0,"shares_display":"115","price_per_share":0.3481,"price_display":"0.35","price_state":"stated","total_value":40.0315,"total_display":"40.03","shares_owned_after":75778.0,"shares_owned_after_display":"75,778","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-14","filed_date":"2023-06-15","scope":"insider"},{"id":8627091,"accession":"0001209191-23-004459","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-004459","line_url":"/filing/0001209191-23-004459#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001767650","owner_name":"Stephenson Pamela","owner_url":"/insider/0001767650","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":102.0,"shares_display":"102","price_per_share":43.8,"price_display":"43.80","price_state":"stated","total_value":4467.6,"total_display":"4,467.60","shares_owned_after":42755.0,"shares_owned_after_display":"42,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-23","filed_date":"2023-01-23","scope":"insider"},{"id":7829766,"accession":"0001209191-23-004225","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-004225","line_url":"/filing/0001209191-23-004225#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001767650","owner_name":"Stephenson Pamela","owner_url":"/insider/0001767650","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1774.0,"shares_display":"1,774","price_per_share":43.9044,"price_display":"43.90","price_state":"stated","total_value":77886.4056,"total_display":"77,886.41","shares_owned_after":42857.0,"shares_owned_after_display":"42,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-19","filed_date":"2023-01-20","scope":"insider"},{"id":9271881,"accession":"0001209191-23-002636","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-002636","line_url":"/filing/0001209191-23-002636#line-1","is_derivative":false,"issuer_cik":"0001767650","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001767650","owner_cik":"0001767650","owner_name":"Stephenson Pamela","owner_url":"/insider/0001767650","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":469.0,"shares_display":"469","price_per_share":19.0614,"price_display":"19.06","price_state":"stated","total_value":8939.7966,"total_display":"8,939.80","shares_owned_after":44631.0,"shares_owned_after_display":"44,631","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-27","filed_date":"2023-01-09","scope":"insider"},{"id":6435852,"accession":"0001209191-22-062701","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-062701","line_url":"/filing/0001209191-22-062701#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001767650","owner_name":"Stephenson Pamela","owner_url":"/insider/0001767650","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":469.0,"shares_display":"469","price_per_share":19.0614,"price_display":"19.06","price_state":"stated","total_value":8939.7966,"total_display":"8,939.80","shares_owned_after":45178.0,"shares_owned_after_display":"45,178","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-27","filed_date":"2022-12-27","scope":"insider"},{"id":6673440,"accession":"0001209191-22-054491","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-054491","line_url":"/filing/0001209191-22-054491#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001767650","owner_name":"Stephenson Pamela","owner_url":"/insider/0001767650","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":104.0,"shares_display":"104","price_per_share":19.5764,"price_display":"19.58","price_state":"stated","total_value":2035.9456,"total_display":"2,035.95","shares_owned_after":45647.0,"shares_owned_after_display":"45,647","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-24","filed_date":"2022-10-25","scope":"insider"},{"id":6517852,"accession":"0001209191-22-051349","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-051349","line_url":"/filing/0001209191-22-051349#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001767650","owner_name":"Stephenson Pamela","owner_url":"/insider/0001767650","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":445.0,"shares_display":"445","price_per_share":19.4049,"price_display":"19.40","price_state":"stated","total_value":8635.1805,"total_display":"8,635.18","shares_owned_after":45751.0,"shares_owned_after_display":"45,751","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-26","filed_date":"2022-09-27","scope":"insider"},{"id":9271880,"accession":"0001209191-23-002635","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-002635","line_url":"/filing/0001209191-23-002635#line-1","is_derivative":false,"issuer_cik":"0001767650","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001767650","owner_cik":"0001767650","owner_name":"Stephenson Pamela","owner_url":"/insider/0001767650","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":106.0,"shares_display":"106","price_per_share":24.6713,"price_display":"24.67","price_state":"stated","total_value":2615.1578,"total_display":"2,615.16","shares_owned_after":45649.0,"shares_owned_after_display":"45,649","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-22","filed_date":"2023-01-09","scope":"insider"},{"id":6105963,"accession":"0001209191-22-043102","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-043102","line_url":"/filing/0001209191-22-043102#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001767650","owner_name":"Stephenson Pamela","owner_url":"/insider/0001767650","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":106.0,"shares_display":"106","price_per_share":24.6713,"price_display":"24.67","price_state":"stated","total_value":2615.1578,"total_display":"2,615.16","shares_owned_after":46196.0,"shares_owned_after_display":"46,196","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-22","filed_date":"2022-07-25","scope":"insider"},{"id":6105693,"accession":"0001209191-22-039597","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-039597","line_url":"/filing/0001209191-22-039597#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001767650","owner_name":"Stephenson Pamela","owner_url":"/insider/0001767650","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":461.0,"shares_display":"461","price_per_share":19.47,"price_display":"19.47","price_state":"stated","total_value":8975.67,"total_display":"8,975.67","shares_owned_after":45755.0,"shares_owned_after_display":"45,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-27","filed_date":"2022-06-28","scope":"insider"},{"id":6123740,"accession":"0001062993-22-015040","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-015040","line_url":"/filing/0001062993-22-015040#line-2","is_derivative":false,"issuer_cik":"0001621443","issuer_name":"Zynerba Pharmaceuticals, Inc.","issuer_ticker":"ZYNE","issuer_name_source":null,"issuer_url":"/issuer/0001621443","owner_cik":"0001767650","owner_name":"Stephenson Pamela","owner_url":"/insider/0001767650","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40.0,"shares_display":"40","price_per_share":1.01,"price_display":"1.01","price_state":"stated","total_value":40.4,"total_display":"40.40","shares_owned_after":28069.0,"shares_owned_after_display":"28,069","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-14","filed_date":"2022-06-16","scope":"insider"},{"id":6482675,"accession":"0001209191-22-025524","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-025524","line_url":"/filing/0001209191-22-025524#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001767650","owner_name":"Stephenson Pamela","owner_url":"/insider/0001767650","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":103.0,"shares_display":"103","price_per_share":32.9247,"price_display":"32.92","price_state":"stated","total_value":3391.2441,"total_display":"3,391.24","shares_owned_after":46216.0,"shares_owned_after_display":"46,216","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-22","filed_date":"2022-04-25","scope":"insider"},{"id":6543128,"accession":"0001209191-22-021442","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-021442","line_url":"/filing/0001209191-22-021442#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001767650","owner_name":"Stephenson Pamela","owner_url":"/insider/0001767650","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":454.0,"shares_display":"454","price_per_share":30.525,"price_display":"30.52","price_state":"stated","total_value":13858.35,"total_display":"13,858.35","shares_owned_after":46319.0,"shares_owned_after_display":"46,319","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-28","filed_date":"2022-03-29","scope":"insider"},{"id":6917919,"accession":"0001209191-22-004805","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-004805","line_url":"/filing/0001209191-22-004805#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001767650","owner_name":"Stephenson Pamela","owner_url":"/insider/0001767650","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":416.0,"shares_display":"416","price_per_share":24.8822,"price_display":"24.88","price_state":"stated","total_value":10350.9952,"total_display":"10,351.00","shares_owned_after":46773.0,"shares_owned_after_display":"46,773","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-24","filed_date":"2022-01-25","scope":"insider"},{"id":5438171,"accession":"0001209191-21-071236","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-071236","line_url":"/filing/0001209191-21-071236#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001767650","owner_name":"Stephenson Pamela","owner_url":"/insider/0001767650","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":474.0,"shares_display":"474","price_per_share":23.9229,"price_display":"23.92","price_state":"stated","total_value":11339.4546,"total_display":"11,339.45","shares_owned_after":25589.0,"shares_owned_after_display":"25,589","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-27","filed_date":"2021-12-27","scope":"insider"},{"id":5165465,"accession":"0001209191-21-057934","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-057934","line_url":"/filing/0001209191-21-057934#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001767650","owner_name":"Stephenson Pamela","owner_url":"/insider/0001767650","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":451.0,"shares_display":"451","price_per_share":32.0537,"price_display":"32.05","price_state":"stated","total_value":14456.2187,"total_display":"14,456.22","shares_owned_after":26063.0,"shares_owned_after_display":"26,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-27","filed_date":"2021-09-28","scope":"insider"},{"id":4786391,"accession":"0001209191-21-043468","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-043468","line_url":"/filing/0001209191-21-043468#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001767650","owner_name":"Stephenson Pamela","owner_url":"/insider/0001767650","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":471.0,"shares_display":"471","price_per_share":36.01,"price_display":"36.01","price_state":"stated","total_value":16960.71,"total_display":"16,960.71","shares_owned_after":26514.0,"shares_owned_after_display":"26,514","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-25","filed_date":"2021-06-28","scope":"insider"},{"id":5245880,"accession":"0001209191-21-023871","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-023871","line_url":"/filing/0001209191-21-023871#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001767650","owner_name":"Stephenson Pamela","owner_url":"/insider/0001767650","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":422.0,"shares_display":"422","price_per_share":34.0174,"price_display":"34.02","price_state":"stated","total_value":14355.3428,"total_display":"14,355.34","shares_owned_after":26985.0,"shares_owned_after_display":"26,985","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-29","filed_date":"2021-03-31","scope":"insider"},{"id":2296296,"accession":"0001209191-20-065364","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-065364","line_url":"/filing/0001209191-20-065364#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001767650","owner_name":"Stephenson Pamela","owner_url":"/insider/0001767650","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":460.0,"shares_display":"460","price_per_share":39.0742,"price_display":"39.07","price_state":"stated","total_value":17974.132,"total_display":"17,974.13","shares_owned_after":21907.0,"shares_owned_after_display":"21,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-28","filed_date":"2020-12-29","scope":"insider"},{"id":3260412,"accession":"0001209191-20-052109","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-052109","line_url":"/filing/0001209191-20-052109#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001767650","owner_name":"Stephenson Pamela","owner_url":"/insider/0001767650","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":451.0,"shares_display":"451","price_per_share":33.2,"price_display":"33.20","price_state":"stated","total_value":14973.2,"total_display":"14,973.20","shares_owned_after":22367.0,"shares_owned_after_display":"22,367","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-25","filed_date":"2020-09-25","scope":"insider"},{"id":2881229,"accession":"0001209191-20-039107","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-039107","line_url":"/filing/0001209191-20-039107#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001767650","owner_name":"Stephenson Pamela","owner_url":"/insider/0001767650","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":397.0,"shares_display":"397","price_per_share":30.79,"price_display":"30.79","price_state":"stated","total_value":12223.63,"total_display":"12,223.63","shares_owned_after":22818.0,"shares_owned_after_display":"22,818","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-25","filed_date":"2020-06-26","scope":"insider"},{"id":3088600,"accession":"0001209191-20-021121","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-021121","line_url":"/filing/0001209191-20-021121#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001767650","owner_name":"Stephenson Pamela","owner_url":"/insider/0001767650","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1785.0,"shares_display":"1,785","price_per_share":17.6,"price_display":"17.60","price_state":"stated","total_value":31416.0,"total_display":"31,416.00","shares_owned_after":23215.0,"shares_owned_after_display":"23,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-25","filed_date":"2020-03-25","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":24,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":24},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001816736","name":"Disc Medicine, Inc.","url":"/issuer/0001816736","role":"Officer (Chief Commercial Officer)","n_filings":2,"first_seen":"2025-02-20","last_seen":"2026-02-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001621443","name":"Zynerba Pharmaceuticals, Inc.","url":"/issuer/0001621443","role":"Director","n_filings":2,"first_seen":"2022-06-16","last_seen":"2023-06-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001322505","name":"ALBIREO PHARMA, INC.","url":"/issuer/0001322505","role":"Officer (Chief Commercial Officer)","n_filings":20,"first_seen":"2020-03-25","last_seen":"2023-01-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001767650","retrieved_at":"2026-08-22T04:44:10+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}